| Primary |
| Drug Use For Unknown Indication |
39.3% |
| Product Used For Unknown Indication |
18.0% |
| Hypertension |
15.5% |
| Benign Prostatic Hyperplasia |
8.4% |
| Blood Cholesterol Increased |
3.6% |
| Cardiovascular Event Prophylaxis |
1.5% |
| Dysuria |
1.5% |
| Prostatomegaly |
1.5% |
| Prostatic Disorder |
1.3% |
| Back Pain |
1.0% |
| Blood Pressure Abnormal |
1.0% |
| Complex Regional Pain Syndrome |
1.0% |
| Osteoarthritis |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Arrhythmia |
0.8% |
| Asthma |
0.8% |
| Blood Pressure |
0.8% |
| Migraine |
0.8% |
| Muscle Spasms |
0.8% |
| Abdominal Pain |
0.5% |
|
| Hypotension |
12.3% |
| Drug Ineffective |
9.9% |
| Dizziness |
8.6% |
| Syncope |
8.6% |
| Neutropenia |
6.2% |
| Tibia Fracture |
4.9% |
| Unevaluable Event |
4.9% |
| Vision Blurred |
4.9% |
| Blood Pressure Decreased |
3.7% |
| Headache |
3.7% |
| Loss Of Consciousness |
3.7% |
| Oedema |
3.7% |
| Orthostatic Hypotension |
3.7% |
| Pollakiuria |
3.7% |
| Priapism |
3.7% |
| Urticaria |
3.7% |
| Alopecia |
2.5% |
| Drug Interaction |
2.5% |
| Dysarthria |
2.5% |
| Erectile Dysfunction |
2.5% |
|
| Secondary |
| Hypertension |
23.0% |
| Drug Use For Unknown Indication |
22.5% |
| Product Used For Unknown Indication |
10.6% |
| Benign Prostatic Hyperplasia |
8.9% |
| Blood Cholesterol Increased |
7.0% |
| Cardiovascular Event Prophylaxis |
2.7% |
| Back Pain |
2.2% |
| Complex Regional Pain Syndrome |
2.2% |
| Prostatomegaly |
2.2% |
| Urinary Tract Disorder |
2.2% |
| Nocturia |
1.9% |
| Anxiety |
1.6% |
| Breakthrough Pain |
1.6% |
| Depression |
1.6% |
| Diabetes Mellitus |
1.6% |
| Diastolic Dysfunction |
1.6% |
| Groin Abscess |
1.6% |
| Migraine |
1.6% |
| Muscle Spasms |
1.6% |
| Neuralgia |
1.6% |
|
| Tibia Fracture |
12.2% |
| Orthostatic Hypotension |
8.5% |
| Pneumonia |
8.5% |
| Drug Hypersensitivity |
7.3% |
| Polyarthritis |
7.3% |
| Syncope |
7.3% |
| Erectile Dysfunction |
4.9% |
| Off Label Use |
4.9% |
| Sexual Dysfunction |
4.9% |
| Drug Ineffective |
3.7% |
| Nocturia |
3.7% |
| Pollakiuria |
3.7% |
| Prostatic Specific Antigen Increased |
3.7% |
| Suicide Attempt |
3.7% |
| Vision Blurred |
3.7% |
| Blood Pressure Decreased |
2.4% |
| Diverticular Perforation |
2.4% |
| Dizziness |
2.4% |
| Flushing |
2.4% |
| Hypotension |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.2% |
| Drug Use For Unknown Indication |
17.0% |
| Hypertension |
14.9% |
| Benign Prostatic Hyperplasia |
4.6% |
| Pain |
4.6% |
| Atrial Fibrillation |
3.1% |
| Depression |
3.1% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Diabetes Mellitus |
2.9% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Multiple Myeloma |
2.7% |
| Blood Cholesterol Increased |
2.4% |
| Arthritis |
2.3% |
| Osteoporosis |
2.2% |
| Prophylaxis |
2.1% |
| Insomnia |
2.0% |
| Prostatomegaly |
1.9% |
| Nuclear Magnetic Resonance Imaging |
1.8% |
| Constipation |
1.8% |
| Cardiac Disorder |
1.6% |
|
| Drug Ineffective |
10.9% |
| Weight Decreased |
10.9% |
| Vomiting |
8.7% |
| Myocardial Infarction |
6.5% |
| Pain |
6.2% |
| Somnolence |
5.2% |
| Vision Blurred |
5.0% |
| Dyspnoea |
4.7% |
| X-ray Abnormal |
4.5% |
| Weight Increased |
4.2% |
| Pneumonia |
3.7% |
| Tremor |
3.7% |
| Headache |
3.5% |
| Nausea |
3.5% |
| Syncope |
3.5% |
| Type 2 Diabetes Mellitus |
3.5% |
| Pruritus |
3.2% |
| Wound Drainage |
3.0% |
| Coronary Artery Disease |
2.7% |
| Hypotension |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
22.6% |
| Product Used For Unknown Indication |
16.1% |
| Diabetes Mellitus |
12.9% |
| Cognitive Disorder |
6.5% |
| Convulsion |
6.5% |
| Hypertension |
6.5% |
| Neuralgia |
6.5% |
| Parkinson's Disease |
6.5% |
| Atrial Fibrillation |
3.2% |
| Benign Prostatic Hyperplasia |
3.2% |
| Hormone Replacement Therapy |
3.2% |
| Nocturia |
3.2% |
| Prostatic Disorder |
3.2% |
|
| Hypertension |
25.0% |
| Asthenia |
12.5% |
| Dysphagia |
12.5% |
| Neoplasm Progression |
12.5% |
| Pneumonia |
12.5% |
| Syncope |
12.5% |
| Trigger Finger |
12.5% |
|
